Glass, senior vice president of global medical affairs at Lilly Cardiometabolic Health, said in a statement on Wednesday
Yes, losing more than 2lbs per week consistently can increase the risk of gallstones and muscle loss
The evidence for GLP-1 medications in treating NASH (the more severe form of fatty liver disease) is particularly impressive: Liraglutide achieved histological resolution of steatohepatitis in 39% of cases after 48 weeks, compared to just 9% in placebo groups 20 Patients taking liraglutide had 4.5 times higher likelihood of NASH resolution than those on placebo 20 Semaglutide demonstrated NASH resolution in 59% of participants versus 17% in placebo groups 21 We offer FibroScan technology to measure liver stiffness and fat content, helping us monitor your progress while on GLP-1 therapy
This hormone slows down digestion and reduces appetite, which can lead to changes in bowel movements, including Ozempic diarrhea
You're reducing inflammation through two independent mechanisms simultaneously dietary and thermal
Maintenance sessions every 6 to 12 months maintain results
